05 Dec

BIBA Delegates Visit HealthBeacon in Dublin

HealthBeacon, a Dublin and Boston based medication adherence technology company that develops Smart Tools for Managing Medication welcomed the Boston Irish Business Association (BIBA) and its 2019 trade mission delegation to it’s Dublin headquarters on Monday, December 2nd.

BIBA Delegates at HealthBeacon HQ

HealthBeacon Co-Founders: Kieran Daly & Jim Joyce

 

 

 

 

 

 

 

 

The purpose of the trade mission is to look at the potential for transatlantic collaboration in order to strengthen links between businesses in Ireland and Boston. The trade mission was led by Laura Hamilton, who is the newly appointed CEO of HealthBeacon’s North American operations.

As President of the Boston Irish Business Association, it was my distinct pleasure to lead an impressive delegation on a Trade Mission across the island of Ireland visiting Belfast, Derry, Donegal, Dublin, Kildare and Cork. A highlight was visiting HealthBeacon HQ in Dublin. It’s been an incredible few weeks since joining the team as their new CEO of North America.” says Hamilton.

HealthBeacon members welcomed the Boston Irish Business Association (BIBA) and its 2019 trade mission delegation BIBA to their facility. HealthBeacon’s CEO, Jim Joyce guided delegates around the HQ touring the Data labs which has a dedicated Data Analyst team serving up valuable actionable insights and analysis, the production lab where the HealthBeacon units are assembled and configured and it’s enthusiastic customer service team which supports the HB offering to patients.

Having the BIBA delegation visit HealthBeacon in Dublin truly showcases the value of growing international business relationships, sustaining the effort, and then capitalizing on opportunities as a result of the endeavor.” Says Hamilton.

HealthBeacon’s technology has been adopted across 13 countries with over 300,000 injections tracked since its launch in 2014 and a patient acceptance rate of 80-90%. For patients that are treated on chronic injectable therapy for conditions that range from Multiple Sclerosis, Crohns Disease, Rheumatoid Arthritis, Asthma, to Severe Migraines many of them fail on therapy due to non-adherence. The data is clear that without support between 40-50% of patients will fail on therapy in the first year.

HealthBeacon’s Smart Sharps Technology has demonstrated a 25-30% increase within twelve months of initiating therapy.  The key to their success is the powerful simplicity of their technology and how it easily integrates into the patient’s routine and the prescribing clinician’s workflow.

HealthBeacon and BIBA Delegates

CEO Jim Joyce welcoming BIBA

CTO, Kieran Daly with Delegates

 

 

 

 

Sr Manager – Contracts & Reimbursements, Alan Dalton

HealthBeacon Smart Sharps Bin

3D Printer

 

04 Dec

HealthBeacon welcomes Boston Irish Business Association to its Dublin HQ

Silicon Republic: Kelly Earley is a journalist with Siliconrepublic.com

HealthBeacon’s new CEO for North America, Laura Hamilton, hopes to strengthen links between businesses in Ireland and Boston.

This week, medtech firm HealthBeacon, which is headquartered between Dublin and Boston, welcomed the Boston Irish Business Association (BIBA) and its 2019 trade mission delegation to the company’s Irish headquarters.

The trade mission was led by Cork-born Laura Hamilton, who is the newly appointed CEO for HealthBeacon’s North American operations. As well as leading the company’s US arm, Hamilton is also the current BIBA president.

The Boston delegation’s visit to HealthBeacon was one stop on a journey through Belfast, Donegal, Derry, Dublin and Cork. The purpose of the trade mission is to look at the potential for transatlantic collaboration. It is hoped that the mission will bring together high-profile US business leaders to grow and strengthen business relationships throughout Ireland.

The BIBA delegates were given a site tour and product overview of HealthBeacon’s Dublin facility, which was led by the company’s co-founder Jim Joyce, who is also a Boston native.

HealthBeacon is developing smart tools for managing medication. Its Smart Sharp Bin aims to make it easier for patients using injectable medicines to stay on track with their treatment schedule and allow carers to track a patient’s progress.

Poised for US growth

Hamilton, who was born in Cork but grew up in Boston, played an instrumental role in bringing BIBA to Ireland for the first time in 10 years.

“After years of planning and discussion, I am thrilled to lead the BIBA trade mission to Ireland, especially as the incoming HealthBeacon CEO for the North American division,” Hamilton said.

“I have been closely connected to HealthBeacon for many years and admire the leadership, the team they’ve developed and early success achieved across Europe.

“The business is poised for tremendous growth in North America through creating value in the healthcare ecosystem with a unique world leading technology, tracking patient adherence with injectable medications for chronic disease.”

To date, HealthBeacon’s platform has been used to track more than 300,000 injections in patient’s homes. The Smart Sharp Bin has been launched in 13 countries.

Joyce said: “I first got to know Laura over four years ago in her time as director of business development at the Massachusetts Biotechnology Council (MassBio) and as BIBA president. HealthBeacon are delighted to appoint a talented business innovator and welcome this important trade mission to our Irish headquarters.”

Since it was founded in 2013, HealthBeacon has raised $15m in funding. Earlier this year, the company announced plans to expand into Asia and the US.

HealthBeacon welcomes Boston Irish Business Association to its Dublin HQ

© 2015 Health Beacon - Privacy Policy - Website by Medusa